MyFinsight
Home
Blog
About
Change in cash, cash
equivalents and restricted...
-$45,255K
(27.49%↑ Y/Y)
Deferred tax expense
(benefit)
$45,333K
(2077.88%↑ Y/Y)
Accounts receivable
-$14,987K
(-209.90%↓ Y/Y)
Prepaid expenses and
other current assets...
-$6,465K
(-149.95%↓ Y/Y)
Depreciation and
amortization
$3,668K
(-48.90%↓ Y/Y)
Stock-based compensation
$3,052K
(-48.35%↓ Y/Y)
Reduction in the carrying
value of right-of-use...
$2,486K
(-39.02%↓ Y/Y)
Adjustment for excess and
obsolete inventories
-$1,269K
(79.17%↑ Y/Y)
Provision recorded for
credit losses
$984K
(-68.42%↓ Y/Y)
Accounts payable
$605K
(-63.04%↓ Y/Y)
Amortization of intangible
assets
$433K
(-74.27%↓ Y/Y)
Loss on disposal of
property and equipment
-$395K
(-797.73%↓ Y/Y)
Other liabilities
$297K
(773.53%↑ Y/Y)
Non-cash interest
expense
$90K
(-35.25%↓ Y/Y)
Net cash used in
operating activities
-$31,653K
(40.06%↑ Y/Y)
Net cash used in
financing activities
-$12,502K
(-433.36%↓ Y/Y)
Net cash used in
investing activities
-$1,100K
(84.86%↑ Y/Y)
Canceled cashflow
$80,064K
Net loss
-$96,267K
(-240.95%↓ Y/Y)
Construction of landlord
assets, net of tenant...
$12,154K
Principal repayments of
finance lease...
$348K
(-39.27%↓ Y/Y)
Purchases of property and
equipment
$1,100K
(-84.86%↓ Y/Y)
Accrued expenses and
other current...
-$9,800K
(29.43%↑ Y/Y)
Inventories
$3,082K
(-80.61%↓ Y/Y)
Operating leases
$1,380K
(-66.72%↓ Y/Y)
Fair value
adjustment to assets held...
-$1,188K
Back
Back
Cash Flow
Organogenesis Holdings Inc. (ORGO)
Organogenesis Holdings Inc. (ORGO)
source: myfinsight.com